What's the Cost of Pancreatic neuroendocrine tumors Diagnosis and Treatment in India?
Pancreatic neuroendocrine tumors treatment cost in India typically ranges from $5,200 to $8,200 for surgical enucleation, while advanced radiosurgery options like CyberKnife run from $4,500 to $6,500. Expenses depend on the tumor stage, tumor grade, and the surgical approach used. Patients can save approximately 60-80% compared to the US. Top cities for this specialized oncology care include Bengaluru, Chennai, and Nashik.
Typical Pancreatic Neuroendocrine Tumors Treatment Costs in India
- Enucleation of tumor on pancreas: $5,200 – $8,200
- CyberKnife: $4,500 – $6,500
- NanoKnife: $6,500 – $10,500
- Actinium-225 Therapy: $5,000 – $8,500
Bookimed Expert Insight: For complex cases, multidisciplinary centers like HCG Manavata Cancer Centre offer high-volume expertise with over 65,000 surgeries performed. Patients requiring advanced diagnostics benefit from facilities equipped with PET-CT and TomoTherapy-H for precise tumor mapping. Dr. Raj Nagarkar, with experience in 50,000+ cancer surgeries, is a leading choice for radical resections. Choosing JCI-accredited Manipal Hospitals ensures international safety standards for international patients.
| India | Turkey | Austria | |
|---|---|---|---|
| NanoKnife | ≈ $6,500 | ≈ $9,500 | ≈ $25,000 |
| Enucleation of tumor on pancreas | ≈ $5,200 | from $10,000 | ≈ $17,500 |
| CyberKnife | ≈ $4,500 | from $3,500 | ≈ $7,500 |
| Actinium-225 Therapy | ≈ $5,000 | from $18,300 | ≈ $12,500 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Pancreatic neuroendocrine tumors treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pancreatic neuroendocrine tumors treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pancreatic neuroendocrine tumors treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Pancreatic neuroendocrine tumors Treatment Centers in India: 3 Verified Options and Prices
Dr. Rela Institute & Medical Centre
HCG Manavata Cancer Centre
Raj Nagarkar




Get a Medical Assessment for Pancreatic neuroendocrine tumors Treatment in India: Consult with 6 Experienced Doctors Now
View all Doctors
Sridhar P.S.
Dr. Sridhar specializes in radiotherapy for pancreatic neuroendocrine tumors at HCG Manavata Cancer Centre, with extensive training in radiation oncology.
- Over 30 years of experience in radiotherapy
- Trained at Banaras Hindu University and National Board of Examination
- Member of Society for Neuro-Oncology and Bangalore Oncology Group
- Diplomate of National Board in radiotherapy

Chaitainya Borde
Dr. Chaitainya Borde has performed over 30,000 PET scans and treated 1,000+ thyroid cancer patients at HCG Manavata Cancer Centre.
- 11 years of experience in nuclear medicine
- Specializes in radioiodine and Lu-177 RN therapies
- Proficient in all types of nuclear scans and PET-CT imaging
- Published researcher in medical journals

Ravindra Tandale
Dr. Ravindra Tandale is a consultant at HCG Manavata Cancer Centre in Nashik. He specializes in anesthesia for surgical oncology, including breast, lung, and liver cancer procedures. Dr. Tandale holds MBBS and DA qualifications.
He works at HCG Manavata, a facility that treats 75,000 patients annually and holds NABL and NABH accreditations. Dr. Tandale manages anesthesia for various surgeries, including procedures for late-stage cancer. He also provides online consultations for preoperative care.

Shruti Kate
Dr. Shruti Kate specializes in pancreatic neuroendocrine tumors, trained at Tata Memorial Hospital – one of India's top cancer centers.
- Expert in Whipple procedure for pancreatic tumors
- Member of ASCO, ESMO, and other leading oncology societies
- Presented lung cancer research at World Conference on Lung Cancer
- Focuses on immunotherapy and metronomic therapy for advanced cancers
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Pancreatic neuroendocrine tumors Treatment in India
How do pancreatic neuroendocrine tumors (pNETs) differ from standard pancreatic cancer, and how does this affect treatment in India?
Pancreatic neuroendocrine tumors (pNETs) originate in hormone-producing cells, whereas standard pancreatic cancer arises from enzyme-producing cells. pNETs usually grow slower and offer better survival rates. Indian hospitals utilize specialized tools like Ga-68 DOTATATE PET-CT scans and Lu-177 PRRT to target these specific islet cell tumors.
- Cellular origin: pNETs develop from endocrine islet cells rather than exocrine digestive cells.
- Surgical approach: Resection including enucleation may cost between $5,500 and $10,500 in India.
- Nuclear medicine: Indian experts like Dr. Chaitainya Borde utilize Lu-177 radiotherapy for advanced cases.
- Non-invasive options: CyberKnife radiosurgery packages in India start from approximately $6,000 to $9,200.
Bookimed Expert Insight: While standard pancreatic cancer requires immediate aggressive surgery, pNET treatment in India focuses on tumor biology. Data shows that specialized centers like HCG Manavata utilize NanoKnife technology, costing around $8,500 to $14,500, for tumors near sensitive vessels where traditional surgery might be too risky. This tech-driven precision allows for treating complex cases that other regions might consider inoperable.
Patient Consensus: Patients emphasize that pNETs are unique and require checking specific details like the Ki-67 index and grade before starting treatment. They often note that a generic cancer diagnosis can change after a specialized pathology review at large Indian tertiary centers.
What are the primary surgical options available in Indian hospitals for pNETs?
Indian hospitals offer surgical options for pancreatic neuroendocrine tumors (pNETs) ranging from organ-sparing enucleation to radical resections. Specialists use robotic systems and laparoscopic techniques to preserve pancreatic function. Choice depends on tumor size, type, and location within the organ.
- Whipple procedure: Removes the pancreatic head, duodenum, and bile duct for head-located tumors.
- Distal pancreatectomy: Resects the pancreatic body and tail, often including the spleen.
- Enucleation: Removes only the tumor capsule to spare healthy tissue and function.
- Central pancreatectomy: Removes the neck or mid-body while reconnecting the head and tail.
- Total pancreatectomy: Full organ removal for widespread or multifocal tumors.
Bookimed Expert Insight: While many hospitals focus on traditional surgery, Dr. Rela Institute & Medical Centre utilizes the Da Vinci robotic system for high-precision pancreatic resections. This technology is particularly effective for organ-sparing procedures like enucleation. Packages for enucleation in India range from $5,500 to $10,500. This is approximately 70% lower than costs in Western Europe or the US for the same robotic approach.
What advanced non-surgical treatments are used in India for metastatic pNETs?
India uses advanced non-surgical treatments for metastatic pancreatic neuroendocrine tumors (pNETs) like Peptide Receptor Radionuclide Therapy (PRRT). Experts apply 177Lu-DOTATATE and 225Ac-DOTATOC to target cancer cells. Facilities also offer CyberKnife radiosurgery and Targeted Alpha Therapy to treat complex cases without invasive surgery.
- Radionuclide therapy: Specialists like Dr. Chaitainya Borde administer Lu-177 and Actinium-225 therapies.
- Interventional radiology: Techniques include Transarterial Chemoembolization (TACE) and Yttrium-90 SIRT for liver lesions.
- Ablation methods: Microwave and radiofrequency ablation destroy small tumors using thermal energy precisely.
- Targeted biotherapy: Medical oncologists prescribe Somatostatin Analogues and Everolimus to stop tumor growth.
Bookimed Expert Insight: Indian oncology centers like HCG Manavata provide a unique concentration of expertise in both nuclear medicine and clinical research. Our data shows specialists like Dr. Raj Nagarkar have participated in over 200 clinical trials. This research focus means patients often access the latest dosing protocols for targeted therapies like immunotherapy and metronomic therapy sooner than at general hospitals.
What are the average survival and success rates reported for pNET treatments in India?
Five-year survival rates for pancreatic neuroendocrine tumors (pNETs) in India range from 40% to 60% overall. Localized tumors show excellent outcomes with 83% to 90% survival. Advanced multidisciplinary centers like Manipal Hospitals and HCG Manavata provide specialized surgical and nuclear medicine interventions.
- Early-stage survival: Localized pNETs (Stage 1 and 2) report five-year survival exceeding 90%.
- Surgical success: Premier Indian facilities achieve 95% to 98% surgical survival for radical resections.
- Nuclear medicine: PRRT with Lutetium-177 DOTATATE increases progression-free survival by over 50%.
- Tumor grade impact: Grade 1 tumors maintain a 77% survival rate over 5 years.
Bookimed Expert Insight: Patient volume serves as a critical quality indicator for complex pNET care. Manipal Hospitals treats 2,000,000 patients annually across 15 facilities. High-volume centers often demonstrate better surgical outcomes. Dr. Chaitainya Borde at HCG Manavata has managed 30,000+ PET scans. This volume suggests high diagnostic accuracy for staging.
Patient Consensus: Patients emphasize that long-term survival requires ongoing monitoring even after surgery. Success is often viewed as maintaining a good quality of life while managing the tumor as a chronic condition.
Which are the top hospitals and specialists for pNET management in India, and what infrastructure should patients expect?
Top Indian hospitals for pancreatic neuroendocrine tumors (pNETs) include Manipal Hospitals, Dr. Rela Institute, and HCG Manavata Cancer Centre. These centers provide infrastructure like Ga-68 DOTATATE PET-CT scans for precise tumor mapping. Specialized nuclear medicine departments offer Lu-177 and Actinium-225 therapies for advanced cases.
- Advanced diagnostics: Functional imaging includes Ga-68 DOTATATE PET-CT and endoscopic ultrasound for staging.
- Specialized theranostics: Facilities offer Peptide Receptor Radionuclide Therapy using Lu-177 or Actinium-225 isotopes.
- Surgical technology: Surgeons utilize da Vinci robotic systems for tumor enucleations and Whipple procedures.
- Ablative options: Interventional oncology suites provide NanoKnife and CyberKnife for localized tumor destruction.
Bookimed Expert Insight: While many seek care in New Delhi or Mumbai, Nashik has emerged as a specialized hub with HCG Manavata Cancer Centre. This facility has managed over 30,000 PET scans and provides rare Actinium-225 therapy. Dr. Chaitainya Borde at this center has treated 1,000+ patients, offering high-volume expertise outside the major metro capitals.
Patient Consensus: Patients emphasize finding a dedicated pancreatic surgeon rather than a general oncologist. They also stress that confirming your Ki-67 grading and proper tumor classification is vital before starting any treatment.








